Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn
- 30 December 2004
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 54 (5), 424-430
- https://doi.org/10.1007/s00262-004-0584-y
Abstract
We have demonstrated previously that the optimal method for inducing an antibody response against defined cancer antigens is covalent conjugation of the antigen to keyhole limpet hemocyanin (KLH) and use of the potent saponin adjuvant QS-21. Single molecules of glycolipids (tetrasaccharides, pentasaccharides, or hexasaccharides) and MUC1 peptides (containing between one and five MUC1 tandem repeats) conjugated to KLH have proven sufficient for antibody recognition and vaccine construction. However, cancer specificity of monoclonal antibodies against the monosaccharide Tn and disaccharide sTn comes largely from recognition of clusters (c) of these molecules on the cell surface. Tn consists of a monosaccharide (GalNAc) O-linked to serine or threonine on epithelial cancer mucins which are uniquely rich in serines and threonines. We test here several Tn constructs: Tn monosaccharide, Tn(c) prepared on a triple threonine backbone, and Tn prepared on a partially or fully glycosylated MUC1 backbone. We determine that Tn(c) is more effective than Tn, and conjugation to KLH is more effective than conjugation to BSA or polystyrene beads for inducing ELISA reactivity against Tn, and FACS reactivity against Tn-positive tumor cells. Surprisingly, MUC1 glycosylated with Tn at three or five sites per 20 amino acid MUC1 tandem repeat and conjugated to KLH, induced the strongest antibody response against Tn and tumor cells expressing Tn, and had the additional advantage of inducing antibodies against MUC1.Keywords
This publication has 14 references indexed in Scilit:
- Detecting O-linked oligosaccharides on glycoproteinsAnalytical Biochemistry, 2003
- Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trialProceedings of the National Academy of Sciences, 2001
- Immunization of ovarian cancer patients with a synthetic Lewisy-protein conjugate vaccine: A phase 1 trialInternational Journal of Cancer, 2000
- Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21International Journal of Cancer, 2000
- Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cellsCancer Immunology, Immunotherapy, 1999
- A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of PrincipleAngewandte Chemie International Edition, 1999
- Cloning of a Human UDP-N-Acetyl-α-d-Galactosamine:PolypeptideN-Acetylgalactosaminyltransferase That Complements Other GalNAc-Transferases in Complete O-Glycosylation of the MUC1 Tandem RepeatJournal of Biological Chemistry, 1998
- Parallel Synthesis and Screening of a Solid Phase Carbohydrate LibraryScience, 1996
- Purification and cDNA Cloning of a Human UDP-N-acetyl-α- D-galactosamine:polypeptide N-AcetylgalactosaminyltransferaseJournal of Biological Chemistry, 1995
- Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).Proceedings of the National Academy of Sciences, 1993